Radiopharmaceutical and methods of synthesis and use thereof

Details Radiopharmaceutical and methods of synthesis and use thereof Radiopharmaceutical and methods of synthesis and use thereof

2008-01-29

2008-01-29

Aulakh, Charanjit S. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C424S001370, C424S009100, C546S048000, C514S284000

Reexamination Certificate

active

07323566

ABSTRACT:
A novel group of apomorphine derivatives are provided that are well suited as radioimaging agents upon incorporation of radionuclides. Through reaction of D ring sites, the less reactive sites of the apomorphine A ring is modified in ways previously unattainable.

REFERENCES:
Simon, C. et al.: Synthesis of C-3 halogen-substituted apocodeines and apomorphines. Synthetic Commun. vol. 21, pp. 2309-2316, 1991.
Hussain, S.F. et al.: A new pentasubstituted aporphine: (+)-N-methyldanguyelline. J. of Natural Products, vol. 52, pp. 428-429, 1989.
Sheppard, H. et al.: The dopamine-sensitive adenylate cyclase of the rat caudate nucleus. Biochemical Pharmacol. vol. 27, pp. 1113-1116, 1978.
Vasdev et al., Selectivity of [F]F2 towards L—Methyltyrosine and L-Tyrosine: A Radiochemical and NMR Spectroscopic Study; J. Labelled Cpd. Radiopharm 44, Suppl.1 2001 S863-S865.
2004 American Chemical Society; pp. 1-29; Absolute Chemistry.
Ajao et al., The Preparation and Oxidative Dimerisation of 2-Acetyl-7-hydroxy-1,2,3,4-tetrahydroisoquinoline Synthesis; Dept. of Chem, Queen Elizabeth College, London,EnglandMar.-Apr. 1984; pp. 329-331.
Langer et al.,Preparation of 4- and 6- [Br]Bromometaraminol, Two Pet Tracers for the Adrenergic Nerve Sysem, J. Labelled Cpd. Radiopharm 40, (1997) 117-119.
DeVos et al., Synthesis of Iodoaminoglutethimide, a Possible Radioligand for the Visualisation of the Aromatase Enzyme in Breast Carcinoma by Spect, J. Labelled Cpd. Radiopharm 40, (1997) 375-376.
C Loc'h et al, Preparation and Preliminary Evaluation of 3-threo Bromomethylphenidate Enantiomers; Potential Tracers for PET Study of Dopamine Reuptake Sites, J. Labelled Cpd. Radiopharm 42, (1999) S42-S44.
Pacer et al., Synthesis of 1-(3-[F]Fluorobenzly)-4-[2(N-Phthalimid-1-yl)Ethyl] Piperidine, J. Labelled Cpd. Radiopharm 44, Suppl.1 (2001); S920-921.
Constantinou et al., Improved Preparation of [F] Xenon Difluoride from [F] Fluoride for Labelling Reactions; J. Labelled Cpd. Radiopharm 42, Suppl 1 (1999), S530-532.
Filer et al., Preparation of (−)-[8,9-H]Apomorphine at High Specific Activity, Journal of Organic Chemistry 1980, 45, 3918-3919.
Cramer et al., Gas Phase Fluorination of Benzene, Fluorobenzene, m-Difluorobenzene and Trifluoromethylbenzene by Reactions of Thermal Fluorine-18 Atoms, Dept of Chemistry, University of CA, Irvine, CA Mar. 12, 1974, 6579-6584.
Berenyi et al.,A New Efficient Method for the Preparation of 2-Fluoro-N-propylnorapomorphine, J.Chem. Soc. Perkin Trans, Jan. 1992, 2693-2694.
Fuchtner et al., 3-O-Methyl-6-[F]Fluoro-L-Dopa-A Promising Substance for Tumour Imaging, J. Labelled Cpd. Radiopharm 42, Suppl. 1 (1999), S267-269.
John et al., Synthesis, Characterization and Initial Clinical Evaluation of 3-[123I]Iodo-N-[2-(1-Piperidinyl) Ethyl]4-Methozybenzamide, [123I] Pimba in Breast Cancer Patients,J. Labelled Cpd. Radiopharm. 42, Suppl. 1 (1999) S261-263.
Nagasawa et al., Synthesis and Dopamine Receptor Affinity of (R)-(−)-2Fluro-N-n-propylnorapomorphine: A Highly Potent and Selective Dopamine D Agonist, J. Med. Chem. 1990, 33, 3122-3124.
Baldessarini et al., R(−) Fluoro-N-Propylnorapomorphine a very Potent and D2-Selective Dopamine Agonist, Neuropharmacology, vol. 30, No. 1, 97-99, 1991.
Vasdev, Synthesis of Fluorine-18 Labeled 5—Fluoro-L-Dopa by Direct Fluorination of L-Dopa, J Labelled Cpd. Radiopharm, 42, Suppl 1(1999), S486-488.
Windhorst et al., Radiosynthesis and Biodistribution of I Labeled Antagonists as Potential Spect Ligands for the Histamine H3 Receptor, J. Labelled Cpd. Radiopharm, 42, Suppl. 1 (1999), S282-283.
Gillings et al., An Improved Synthesis and Evaluation in Pig Brain of the Dopamine Agonist Ligand: R-[N-Methyl-C] Apmorphine, J. Labelled Cpd. Radiopharm, 44, Suppl. 1(2001), S210-212.
Ramsby et al., 2-Haloaporphines as Potent Dopamine Agonists, J. Med. Chem 1989, 32, 1198-1201.
Morin et al., N-Monofluoroalkylnoraporphines Synthesis and Binding Dopamine Receptor Studies, Med. Chem Res (1992) 2:354-360 1992.
Tierling et al., A New Nucleophilic Asymmetric Synthesis of 6-[F] Fluoro-Dopa, J. Labelled Cpd. Radiopharm. 44, Suppl. 1 (2001), S146-147.
Weisbach et al., Studies in the Synthesis and Pharmacology of Aporphines, Journal of Medicinal Chemistry, vol. 6, No. 2, Mar. 6, 1963, 91-97.
Zijlstra et al., Synthesis and In Vivo Distribution in the Rat of Several Fluorine-18 Labeled N-Fluoroalkylaporphines, Appl. Radiat. Isot. vol. 44, No. 4, 651-658, 1993.
Cumming et al., Kinetics of the uptake and distribution of the dopamine D2,3 agonist (R)-N-[1-11C]n-propylnorapomorphine in brain of healthy and MPTP-treated Bottingen miniature pigs, Nuclear Med and Bio 30 (2003) 547-553.
Filer et al., Isoquinolines.7.Reaction of Ethylene Oxide with Ioquinolines. Novel Isoquinolone and Oxazolidine Formation, J. of Organic Chemistry 43, 672 (1978), 673-678.
Filer et al, Aporphines. 28.Preparation of (−)-N-n[3H-and-2H] Propylnorapomorphine, J. Org. Chem. 1980, 45, 3465-3467.
Koziorowski et al., Rapid Preparation of 5-[I]iodo-2-Deoxyuridine by iododestannylation, J. Labelled Cpd. Radiopharm 40, 128 (1997).
Argiolas et al., N-n-Propyl-Norapomorphine: An Extremely Potent Stimulant of Dopamine Autoreceptors, Brain Research, 231 (1982) 109-116.
Hwang et al., (−)-N[C] Propyl-Norapomorphine: A Positron-Labeled Dopamine Agonist for PET Imaging of D2 Receptors, Nuclear Medicine & Biology, vol. 27, pp. 553-539, 2000.
Halldin et al., PET Studies with Carbon-11 Radioligands in Neuropsychopharmacological Drug Developement, Current Pharmaceutical Design, 2001, 7, 1907-1929.

Affiliated with

Also associated with

Rating

Radiopharmaceutical and methods of synthesis and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiopharmaceutical and methods of synthesis and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiopharmaceutical and methods of synthesis and use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2776326